Close Menu
Home » Trovagene's Dual-Sample Liquid Biopsy Performs Well in First Peer-Reviewed Study

Trovagene's Dual-Sample Liquid Biopsy Performs Well in First Peer-Reviewed Study

Jul 29, 2016
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – A new study this week by Trovagene and its academic collaborators is the first to demonstrate the validity of the company's liquid biopsy strategy for detecting EGFR mutations in both blood and urine of patients with lung cancer.

The paper, published online in the Journal of Thoracic Oncology this week, is an important step for Trovagene toward broadening adoption if its tests beyond what is currently a relatively small corps of early adopters, company officials told GenomeWeb.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Diversity of African Genomes

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

'We Gotta Change These Numbers'

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Science Like a Girl

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

Science Looks at Beneficial Genetic Variants in the Melanesian Population, and More

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.

Oct
21
Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Sponsored by
Agilent

Genomics is a key element in the potential of precision medicine to transform oncology. 

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
04
Featured Webinar

Digital Solutions for NGS Genotyping – Accuracy, Clinical Relevancy, and Report Generation

Sponsored by
Roche

This webinar will provide a look at how the Institute of Hematopathology in Hamburg, Germany, is implementing complex genomic testing for lung cancer. 

What's Popular?

In Molecular Diagnostics

  1. Color, Ochsner Health System Collaborating on Population Health Pilot

  2. Roche Revenues Grow 10 Percent in First Nine Months of 2019

  3. Ancestry Begins Genetic Testing Services for Health

    Premium

  4. Natera Prices $200M Common Stock Offering

  5. Natera Plans Stock Offering Worth up to $201.3M; Expects Q3 Revenue Gain Above Consensus Estimate

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.